PROGRAM MAY 10-14 (WESTERN HEMISPHERE) MAY 11-15 (EASTERN HEMISPHERE) - CONNECT AND COLLABORATE THROUGH BIOBANKING: POWERING INNOVATION AND ...
←
→
Page content transcription
If your browser does not render page correctly, please read the page content below
CONNECT AND COLLABORATE THROUGH BIOBANKING: POWERING INNOVATION AND DISCOVERY PROGRAM MAY 10–14 (WESTERN HEMISPHERE) MAY 11–15 (EASTERN HEMISPHERE)
Connect Globally to Leading
Professionals in Biobanking JOIN ISBER
ISBER’s vision is to be the leading network in the global
TODAY!
biobanking and biorepository community.
ISBER advances the expertise and quality of biorepositories
and biobanking science worldwide. WWW.ISBER.ORG
BENEFITS OF MEMBERSHIP INCLUDE:
Free access to the ISBER Best Practices for Repositories and ISBER
Biobank Assessment Tool (BAT)
Opportunity to connect with a global group of professionals in biobanking
through the ISBER Members-only Forum
Access to Biopreservation and Biobanking (BIO), ISBER’s official journal
Reduced registration rates to ISBER meetings
Stay informed with the latest biorepository news through the online ISBER News
NEW ISBER MEMBERS RECEIVE
15% OFF THEIR FIRST-YEAR OF MEMBERSHIP!
READY TO JOIN? VISIT ISBER.ORG!
Head Office: Suite 301, 750 West Pender Street, Vancouver, BC, Canada, V6C 2T7
leading since 1999 T: 1-604-484-5693 • F: 1-604-874-4378 E: info@isber.org W: www.isber.org
PROGRAM
To be the leading network in the global
Vision biobanking and biorepository community.
ISBER advances the expertise and quality
Mission of biorepositories and biobanking science
worldwide.
International Society for Biological and Environmental Repositories
750 Pender Street, Suite 301, Vancouver, BC V6C 2T7 Canada | T 604.484.5693 | F 604.874.4378 3
PROGRAM
ISBER SPONSORS
GOLD SPONSORS:
SILVER SPONSORS:
BRONZE SPONSORS:
4
PROGRAM
TABLE OF CONTENTS
Message from the ISBER President and Scientific Program Committee..................................6
ISBER Board of Directors and Committee Chairs............................................................... 10
ISBER Committee, Working Group and SIG Listing............................................................11
ISBER 2021 Award Recipients........................................................................................ 13
General Conference Information.................................................................................... 14
Description of Virtual Session Types................................................................................ 15
Conference-at-a-Glance................................................................................................ 16
Conference Program.................................................................................................... 18
Speaker and Workshop Presentation Summaries.............................................................. 31
Round Table Discussion Summaries................................................................................46
Abstract Poster Listing..................................................................................................49
Exhibitor Listing...........................................................................................................53
5
PROGRAM
MESSAGE FROM THE ISBER PRESIDENT AND SCIENTIFIC
PROGRAM COMMITTEE
Dear Colleagues and friends, ISBER 2021 will host a wide range of experts working in the
different steps of the same food chain, academia, hospitals,
Welcome to the International Society for Biological and
biological & life sciences, clinical diagnostics, and pharma
Environmental Repositories (ISBER) 2021 Annual Meeting.
biotech. Those experts will share their experience and dis-
While we do not have a host city this year, we have the
cuss how closer collaboration can lead to more successful
opportunity instead to present our meeting virtually to the
future research and development and address the needs to
world! This year will be ISBER’s first completely virtual meet-
facilitate such collaboration.
ing and we are anxious and excited to share our colleagues’
research!
PRE CONFERENCE WORKSHOP
Our theme this year is, “Connect and Collaborate through
Biobanking: Powering Innovation and Discovery,” and this The annual meeting begins this year with the Biobanking
year has certainly been a year of connecting and collaborat- 101 workshop held virtually from April 28th-29th. Topics of
ing for everyone. While we have always connected and col- discussion were the Qualification of Biorepository Science
laborated with fellow biobankers, this past year it has been (QBRS), emergency planning for biobanking, and basic
more important than ever to bring together experts in their business planning for biobanking.
fields to share their knowledge and experience with ISBER
members around the globe. PROGRAM HIGHLIGHTS
Biobanks are among the most important enablers of med- World leaders have been invited by our Scientific Program
ical research and pharmaceutical development. Be it aca- Committee to present in their areas of expertise. The four
demic research in hospitals, diagnostic test development in day program includes round table discussions, a Keynote
biotechnological institutes or R&D of vaccines or drugs in address, eleven symposia sessions, four contributed paper
pharmaceutical companies, they all depend on the crucial sessions, six educational workshops, networking opportu-
data encapsulated in biological samples. And all of those nities, and opportunities to network with ISBER members
scientists are dedicated to one common vision: improving and learn from our corporate sponsors during sponsor
quality of life and health care. showcase presentations, corporate workshops, and within
the exhibit hall.
Availability of high quality biological samples, however, can-
not be taken for granted and reaching that common vision With this year being the first year that ISBER has hosted a
oftentimes does not come easy. To overcome existing ob- virtual meeting, we have the unique opportunity to have our
stacles, we need one thing above all: more collaboration. speaker’s presentations available for on-demand viewing af-
Collaboration requires the realization that all of us are in the ter the conclusion of the conference. Additionally, we have
same boat and are pulling in the same direction. It requires asked our ISBER members to submit biobank profile videos
the realization that together we are stronger. highlighting their unique biobank operations.
As devastating as the COVID-19 pandemic has been for the On Monday and Wednesday afternoons, there are a num-
world it has at least shown us the truth in those assumptions. ber of educational workshops to choose from. These have
Never have diagnostic tests, or vaccines, been successfully been submitted by the biobanking community to share
developed with such speed. Keeping up and promoting knowledge and expertise with the ISBER audience.
the spirit of collaboration is what the ISBER 2021 confer- We were thrilled to have over 80 abstract submissions for
ence is about. our conference this year! Four contributed paper sessions
6
PROGRAM
will be held on Tuesday and Thursday afternoons where se- Symposium 2B, “The Nurture of Nature”, provides a plat-
lected topics of research will be presented. Additionally, a form to discuss the vastly diverse environmental collections
virtual poster session will be available to attendees with a that serve as an invaluable resource of knowledge and tell
wide range of biorepository topics of interest. Samples from stories from environmental biobanks and the value they pro-
the moon, anyone? vide for the biobanking community.
PLENARY SYMPOSIA Wednesday, May 12
Wednesday morning begins with our first round table dis-
Monday, May 10
cussions of the annual meeting. Topics of discussion in dif-
On the first day of the meeting, our ISBER President, ferent virtual meeting rooms range from biobanking in LMIC
Associate Professor Daniel Catchpoole, will provide a wel- in the post COVID-19 era, auditing tools, integrating new
come to our attendees, followed by a, “Top of the Morning” collections, NMR tools, cell and gene therapy, and compli-
address from Scientific Program Co-Chairs Amanda Moors ance experience in the pharma industry.
and Benjamin Otto. Next, we will have our Keynote address
Immediately following the round table discussions, we will
from Dr. Jim Vaught. Dr. Vaught is one of ISBER’s founding
welcome our attendees with a morning brief followed by
members and served two terms as president. He has spent
two concurrent symposia. Symposium 3A, is ISBER’s first
over 20 years dedicated to biospecimen sciences and re-
Symposium on the field of food standards and biobanking,
ceived the ISBER Founder’s Award in 2018.
“Biobanking in the Food industry: Where Standards are Easy
Two concurrent symposia will take place on Monday to Digest.” In Symposium 3B, “Biobanking Sustainability
morning, all with equally intriguing topics of discussion. in the Light of the COVID-19 Pandemic”, speakers will share
Symposium 1A, “Lessons learned from the COVID-19 their perspectives and lessons-learned from before, during
Pandemic”, will highlight the collaboration and sharing of and on emerging from the pandemic, on the value and
expertise of samples and of data across academia, industry practicality of sustained biobanking.
and governmental institutions demonstrating how it is vital
Wednesday afternoon will host three concurrent workshops.
for medical research, for successful development of diag-
nostics tests and treatments but as well for sustainability of Thursday, May 13
research projects. In Symposium 1B, “The Microbiome -
On Thursday morning, we will open with a networking
Making a Macro-Impact”, researchers will discuss microbi-
event, followed by a welcome and meeting brief. Two con-
ome collections, and possibilities and limitations associated
current symposia will follow. Symposium 4A, “Making
with microbiome research.
Biospecimens an Informatics Challenge: Navigating Our
Monday afternoon, three concurrent educational work- Way to Innovation,” takes a look at samples through a lens
shops will take place. where the main value of the sample is the information en-
capsulated within and where biospecimens are integral to
Tuesday, May 11
an informatics driven discovery process, and engaging with
On Tuesday morning, we will welcome our members with the informatics industries as active partners. In Symposium
a networking event and morning brief, then two concurrent 4B, “Data Sharing Network for Sharing Evidence-Based
symposia follow. Symposium 2A, “Research and Treatment Solutions,” information will be shared highlighting how bio-
for All – Connecting Research and Implementation to banks play a crucial role in providing tools to examine data
Underserved and Vulnerable Communities,” highlights from those receiving treatment, those being vaccinated,
the importance of including underserved and vulnerable along with reviewing the current and long treatment out-
communities in biobanking and a roadmap to address comes associated with the novel coronavirus disease.
the missing communities and populations. Concurrently,
7
PROGRAM
CONTRIBUTED PAPERS SESSIONS, CORPORATE ACKNOWLEDGEMENTS
WORKSHOPS, AND POSTER PRESENTATIONS
Our annual meeting would not have had such amazing
Contributed Papers Sessions success without our invited speakers, guests, and work-
There are four contributed paper sessions to be held on shop presenters; thank you very much for your contribution
Tuesday and Thursday afternoons. Selected abstracts were to the biobanking community and for making ISBER 2021
submitted, reviewed, and selected for presentation. a success! Members of the ISBER 2021 Scientific Program
Committee, as well as the Organizing Advisory Committee
Corporate Workshops (OAC), contributed a tremendous amount of time and price-
less energy over the past year to present a comprehensive
Be sure to attend the corporate workshops taking place on
annual meeting to ISBER members.
Tuesday, May 11. Hamilton Storage will be presenting on
transitioning to an automated biobank, including advantag- We greatly appreciate the support received from our ven-
es, best practices, and a case study. Agilent Technologies dors and sponsors whose participation also made our meet-
will be presenting on biobank sample quality control with ing successful. Please visit the virtual exhibit hall and attend
automated electrophoresis. Lastly, GA International will be the corporate workshops.
presenting on breakthrough labeling technologies for bio-
Thank you to the ISBER Head Office staff for their support
banks and high-throughput labs.
and guidance throughout this year under the guidance of
Ana Torres. We are very thankful to Samantha Wale for her
POSTER SESSIONS
patience and guidance as we navigated through planning
This year, 63 posters will be presented in a virtual poster our first virtual conference.
hall. Poster presentations will also be considered for ISBER ISBER 2021 is not intended to be a once a year event. To en-
Poster Award which recognized excellence in poster pre- sure future successful meetings, consider joining an ISBER
sentations at the annual meeting. The goal of the ISBER committee, or complete the online survey at the end of the
poster award is to encourage ISBER members and all at- meeting. We hope that this gathering of colleagues will the
tendees of the annual meeting who are new investigators start, or continue, a great future of even stronger collabora-
in biobanking to ask important, original questions about tion and networking, and this is our invitation to join us on
biobanking and biospecimen science, to design sound, this journey.
controlled experiments with a clear rationale, and to pres-
ent the results clearly in a poster format. Thank you for your participation and enjoy the meeting.
With kindest regards,
Daniel Catchpoole, PhD, FFSc
ISBER President, 2021-2022
Amanda Moors
Co-Chair of the ISBER 2021 Scientific Program Advisory Committee
Benjamin Otto
Co-Chair of the ISBER 2021 Scientific Program Advisory Committee
8
ULTRA LOW TEMPERATURE FREEZERS:
KEY CONSIDERATIONS FOR COVID-19 VACCINES
Many cold chain issues occur in the “last mile/kilometre”
of vaccine distribution, with samples lost due to improperly
ULTRA LOW TEMPERATURE FREEZERS:
handled freezers. ISBER, the International Society for KEY CONSIDERATIONS FOR COVID-19 VACCINES
Many cold chain issues occur in the “last
Biological and Environmental Repositories, offers our shared
For more information on the
mile/kilometre” of vaccine distribution, with Best Practices referenced here visit
samples lost due to improperly handled (or scan QR Code):
isber.org/page/BPR
freezers. ISBER, the International Society for Training Resources available at:
Biological and Environmental Repositories, isber.org/page/webinars-on-demand
expertise in cold chain management to educate new users offers our shared expertise in cold chain
management to educate new users of ultra-
low temperature (ULT) -70C freezers as part of STAFF TRAINING
SARS-COV-2 vaccine distribution programs. IS CRITICAL
of ultra-low temperature (ULT) -70°C freezers as part of the This document is intended to
provide guidance for managing the
o Provide all vaccination staff
with proper training in cold
chain supply, freezer operations
and frozen sample handling.
deployment of frozen COVID vaccines.
SARS-COV-2 vaccine distribution programs. ULT FREEZER SELECTION MUST ISBER Best Practices C.3. Mechanical Freezers
& B.5. Backup Power
MEET LOCAL REQUIREMENTS
o Choose freezers with the widest temperature range to accommodate vaccine
candidates and choose the smallest freezer required.
o Confirm the power configuration available in your lab prior to purchase, especially in
o STAFF TRAINING IS CRITICAL
areas with low-grade power supply.
o Have a dedicated backup power system in place in case of power outage.
o Install an independent internal thermometer sensor to log/alert against temperature
fluctuations. Ensure internet or Wi-Fi access and send alerts to multiple staff.
o ULT FREEZER SELECTION MUST ULT FREEZER
INSTALLATION
ULT FREEZER
OPERATION AND
MEET LOCAL REQUIREMENTS
REQUIRES A SPECIFIC MAINTENANCE MUST
STORAGE AREA BE COORDINATED
ULTRA-LOW TEMPERATURE FREEZERS ISBER Best Practices B. Facilities ISBER Best Practices C.12 Equipment Maintenance
o Access to vaccines needs a strict procedure
KEY CONSIDERATIONS FOR COVID-19 VACCINES:
o Each freezer requires an independent circuit.
Ensure outlets are on an emergency circuit for how staff will manage door openings.
o ULT FREEZER INSTALLATION
Aim for few and short door openings to avoid
SUPPLEMENT with built-in redundancy.
o Ensure room where freezer will be housed
freezer temperature fluctuations. Allow the
can handle additional heat load. ULT units will freezer to return to set temperature.
CONTRIBUTORS: o Avoid an empty unit. If you do not have
increase humidity and temperature.
product to fill the unit, consider adding
o ULT freezers need to pull air in
REQUIRES A SPECIFIC
• Dan R. Catchpoole, President, ISBER.; Biospecimen Research Services, CCRU, Kids Research, Sydney Children’s Hospital Network, Westmead,
and exhaust without restriction. empty aluminum racks to fill it.
Australia. Daniel.catchpoole@health.nsw.gov.au
• Piper Mullins, President Elect, ISBER; Smithsonian Institution, Washington, DC, USA. MullinsP@si.edu Check clearance requirements o Regularly clean the
• Jim Vaught, Editor-in-Chief, Biopreservation & Biobanking, USA. jvaught44@gmail.com outlined by each manufacturer condenser and gaskets
• Cheryl Michels, Freezerworks, USA. cheryl@dwdev.com before purchase. to prevent ice formation,
• Monique Albert, Secretary, ISBER; Ontario Tumour Bank, Ontario Institute for Cancer Research, Canada. Monique.Albert@oicr.on.ca especially around doors.
STORAGE AREA o Ensure ULT freezers are
• Alison Parry Jones, Director-at-Large for Europe, the Middle East and Africa, ISBER; Wales Cancer Bank, Wales. Parry-JonesA@cardiff.ac.uk
• Daniel Simeon Dubach, Chair, Standards Committee ISBER; Medservice, Switzerland. daniel.simeon-dubach@medservice.ch calibrated for accuracy of
• Molly Ferrara, Hamilton Storage Technologies Inc, USA. mferrara@hamilton-storage.com temperature display.
• Ian Pope, IC Biomedical, USA. ipope@icbiomedical.com
• Tim Root, Stirling Ultracold, USA. troot@stirlingultracold.com
• Mark Sawicki, Cryoport Systems, USA. msawicki@cryoport.com ULT FREEZER
• Pasquale De Blasio, Integrated Systems Engineering, Italy. pasquale.deblasio@isenet.it
EMERGENCY PLANNING
o ULT FREEZER OPERATION
• Andy Pazahanick, Select Gases, USA. apazahanick@selectgases.com
• Tracy Fogle, Diversified Laboratory Repair, Inc. USA. tfogle@dlrepair.com
• Buzz Bies, MVE Biological Solutions, USA. Buzz.bies@MVEbio.com ISBER Best Practices B.8 Emergency Preparedness
o Draft an emergency plan in case
Many cold chain issues occur in the “last mile/kilometre” of vaccine distribution, with samples of lostfreezer
due to failure, power outage,
AND MAINTENANCE MUST BE
improperly
natural
handled freezers. ISBER, the International Society for Biological and Environmental Repositories, offers disaster,
our shared and other
expertise
in cold chain management to educate new users of ultralow temperature (ULT) -70°C freezers as part common hazards.
of COVID-19 vaccine
distribution programs. o Have a written procedure
for transferring specimens to
COORDINATED
alternative storage (e.g. dry ice).
For more information on the Best Practices referenced here visit
(or scan QR Code): isber.org/page/BPR
www.isber.org
PURPOSE
o ULT FREEZER EMERGENCY
This document is intended to provide guidance managing the deployment of frozen COVID-19 vaccines. It is not designed to be
a comprehensive series of instructions on cold chain management. Rather this is designed to be a guide to the considerations
that need to be addressed by managers wishing to set up a robust system for the SARS-CoV-2 vaccine deployment.
PLANNING
For more information on the
Best Practices referenced here visit
(or scan QR Code):
isber.org/page/BPR
Training Resources available at:
isber.org/page/webinars-on-demand
www.isber.org
PROGRAM
ISBER BOARD OF DIRECTORS AND COMMITTEE CHAIRS
ISBER BOARD MEMBERS
Daniel Catchpoole, PhD, FFSc Debra Leiolani Garcia, MPA Piper Mullins, MS
PRESIDENT 2020-2021 PAST-PRESIDENT 2020-2021 PRESIDENT-ELECT 2020-2021
Tumor Bank, The Children’s Hospital at California, United States Smithsonian Institution
Westmead Washington DC, United States
New South Wales, Australia
Jane Carpenter, MAppSci Monique Albert, MSc, PMP
TREASURER SECRETARY
NSW Health Pathology Ontario Institute for Cancer Research
New South Wales, Australia Ontario, Canada
ISBER BOARD MEMBERS: DIRECTORS-AT-LARGE
Diane McGarvey, QBRScm Xun Xu, PhD Alison Parry-Jones, PhD, MA, MRSC
DIRECTOR-AT-LARGE - Americas DIRECTOR-AT-LARGE - China DIRECTOR-AT-LARGE - Europe, Middle
CHTN Eastern Division China National GeneBank East, and Africa
Pennsylvania, United States Guangdong, China Wales Cancer Bank - Cardiff University
South Glamorgan, United Kingdom
Koh Furuta, MD, PhD EXECUTIVE DIRECTOR
DIRECTOR-AT-LARGE - Indo-Pacific Rim Ana Torres, BA (Hon), MPub, CAE
Director, Urayasu Warakuen Clinic British Columbia, Canada
Urayasu, Japan
COMMITTEE CHAIRS
Catherine Seiler, PhD Kristina E. Hill, MPH, MT(ASCP) Shonali Paul, BE, MBA
COMMUNICATIONS COMMITTEE CHAIR EDUCATION AND TRAINING MEMBER RELATIONS COMMITTEE CHAIR
H3 Biomedicine COMMITTEE CHAIR CloudLIMS.com
Massachusetts, United States Independent Consultant Madhya Pradesh, India
Florida, United States
Zisis Kozlakidis, PhD, MBA, FLS Marianna Bledsoe, MA Daniel Simeon-Dubach, MD, MHA
ORGANIZING COMMITTEE CHAIR SCIENCE POLICY COMMITTEE CHAIR STANDARDS COMMITTEE CHAIR
IARC/WHO Independent Consultant medservice
Auvergne-Rhône-Alpes, France Colorado, United States Walchwil, Switzerland
10PROGRAM
ISBER COMMITTEE, WORKING GROUP, AND SPECIAL INTEREST
GROUP LISTING
EDUCATION & TRAINING ORGANIZING ADVISORY STANDARDS ADVISORY 2021 PROGRAM
ADVISORY COMMITTEE COMMITTEE COMMITTEE COMMITTEE
Chair: Kristina Hill Chair: Zisis Kozlakidis Chair: Daniel Simeon-Dubach Co-Chair: Amanda Moors
Members: Vice Chair: Judita Kinkorova Vice-Chair: Clare Allocca Co-Chair: Benajmin Otto
Ahmed Abdelhafiz Vice Chair: Billy Schleif Monique Albert Monique Albert
Marta Castelhano Members: Cory Arant Catherine Alix-Panabieres
Diane McGarvey Monique Albert Sergey Anisimov Nahla Afifi
Kathy Sexton Daniel Catchpoole Karolin Bergenstrahle Clare Allocca
Tamsin Tarling Jane Carpenter Yehudit Cohen Jane Carpenter
Jason Chen Annemieke De Wilde Daniel Catchpoole
MEMBER RELATIONS Debra Garcia Bonginkosi Duma Debra Garcia
Marianne Henderson Helena Ellis Lotte Glück
ADVISORY COMMITTEE Diane McGarvey Koh Furuta Oliver Karch
Chair: Shonali Paul Amanda Moors Samantha Higgins Cari Lichtman
Members: Piper Mullins Shannon McCall Diane McGarvey
Judith Giri Benjamin Otto Timothy Sharp Kirstin Goldring
Marianne Henderson Alison Parry-Jones Karine Sargsyan Elaine Gunter
Piper Mullins Andy Pazahanick Brent Schacter Marianne Henderson
Benjamin Otto Ayat Salman Weiping Shao Cheryl Michels
Yunice Shao Brent Schacter Rajeev Singh Piper Mullins
Rosy Singh Daniel Simeon-Dubach Emma Snapes Morten Oien
Xuexun Zhou Carmen Swanepoel Suenne Orth
Avashoni Zwane COMMUNICATIONS Dana Valley Shonali Paul
Judita Kinkorova Ran Wang Andy Pazahanick
ADVISORY COMMITTEE Peter Watson Pascal Puchois
Chair: Catherine Seiler Daniel Simeon-Dubach
NOMINATING COMMITTEE YanRu Su
Vice-Chair: Ayat Salman
Robert Hewitt SCIENCE POLICY Tatsuaki Tsuruyama
Chair: Debra Garcia
Emily Hubbard ADVISORY COMMITTEE Hanh Vu
Members:
Lise Matzke Heidi Wagner
Buzz Bies Chair: Marianna Bledsoe
Jim Vaught Andy Zaayenga
Daniel Catchpoole Vice-Chair: Helen Morrin
Rongxing Gan Carol Weil
Andy Zaayenga Members: ISBER WORKING GROUPS
Allison Hubel Kelsey Dillehay McPhillip
William Mathieson Aaron Goldenberg
Diane McGarvey • Biospecimen Science
FINANCE COMMITTEE Catherine Kennedy • Enviro-Bio
Shonali Paul Rita Lawlor
Alison Parry-Jones Chair: Jane Carpenter • Informatics
Tohru Masui • International Repository
Andy Pazahanick Members: Michaela Mayrhofer
Brent Schacter Monique Albert Locator
Elizabeth Mayne • Pharma
Kathi Shea Daniel Catchpoole Alison Parry-Jones
Debra Garcia • Rare Diseases
Brent Schacter • Regulatory and Ethics
GOVERNANCE Jesus Monico Lana Skirboll
Piper Mullins Caoimhe Vallely-Gilroy
COMMITTEE Rajeev Singh ISBER SPECIAL INTEREST
Carol Weil
Chair: Monique Albert GROUPS
Members:
Monique Albert • Automated Repositories
Koh Furuta • Next Generation Living
Debra Garcia Biobank
Alison Parry-Jones • Pediatric
Billy Schlief • Donors
Stella Somiari
Heidi Wagner
11PROGRAM
ISBER 2021 AWARD RECIPIENTS
ISBER OUTSTANDING ACHIEVEMENT IN BIOBANKING
The ISBER Award for Outstanding Achievement in Biobanking is designed to recognize individuals who have made out-
standing contributions to the field of biobanking. The award can be given for a single outstanding achievement or a lifetime
body of outstanding work in the field.
ANDREW BROOKS, USA
ISBER PIONEER’S AWARD
The ISBER Pioneer’s Award, sponsored by MVE Biological Solutions, recognizes individuals who provided outstanding lead-
ership to the founding, support, and incorporation of ISBER as an international biobanking society, as well as long standing
contributors who have played critical roles in developing and executing ISBER’s vision and mission.
FAY BETSOU, LUXEMBOURG
ISBER DISTINGUISHED LEADERSHIP AND SERVICE AWARD
The ISBER Distinguished Leadership and Service Award is designed to honor ISBER members who have demonstrated
exceptional leadership to further the mission and goals of the society and/or significant, long-standing contributions to
the society.
NICOLE SIEFFERT, USA
ISBER SPECIAL SERVICES AWARDS
The ISBER Special Service Awards recognize individuals who have made exceptional contributions towards the goals of the
Society through the performance of a special service or act on behalf of the organization.
CLARE ALLOCCA, USA
KAROLIN BERGENSTRÅHLE, SWEDEN
ANUSHA HETTIARATCHI, AUSTRALIA
BILLY SCHLEIF, USA
HEIDI WAGNER, CANADA
BIRENDRA YADAV, INDIA
13PROGRAM
GENERAL CONFERENCE INFORMATION
EDT = American Eastern Daylight Time BIOBANKING 101 WORKSHOP
PRE-REGISTRATION REQUIRED
VIRTUAL PLATFORM The Biobanking 101 workshop is taking place over two days:
All delegates have been provided with a personal link to
join the meeting platform via email. If you do not have this Wednesday, April 28 2:30pm – 5:00pm
link, you may go to the following link and enter your email SUCCESS IS THE RESULT OF PREPARATION: EMERGENCY
address to be re-sent your login link: PLANNING FOR BIOBANKS
QUALIFICATION IN BIOREPOSITORY SCIENCE
https://isber.econference.io/public/4irSk29
CONFERENCE SUPPORT: Thursday, April 29 10:00am – 12:00pm
BASIC BUSINESS PLANNING FOR BIOBANKING
Thursday, May 6 11:00pm – 1:00am
Friday, May 7 11:00am – 2:00pm
Monday, May 10 9:00am – 5:00pm TO REGISTER, CLICK HERE
Tuesday, May 11 9:00am – 5:00pm
Wednesday, May 12 9:00am – 5:00pm NETWORKING EVENTS/LOUNGE
Thursday, May 13 9:00am – 5:00pm
Various networking activities have been planned throughout
EXHIBIT HOURS: the meeting. Furthermore, all delegates are able to look up
and connect with other delegates throughout the meeting
Exhibit booths will be available throughout the entirety of using the “attendee listing”. Specific networking activities are
the meeting. Specific visiting hours are: scheduled as follows:
Monday, May 10 10:45am – 11:15am Tuesday, May 11:
Tuesday, May 11 11:00am – 11:30am • 8:45 – 9:30am: Drop-in networking in lounge
Wednesday, May 12 11:00am – 11:30am, • 7:15pm – 8:00pm: Drop-in networking in lounge
9:30pm – 10:30pm Wednesday, May 12:
Thursday, May 13 11:00am – 11:30am • 8:45 – 9:30am: Round Table Discussions
• 7:15pm – 8:00pm: Round Table Discussions
REGISTRATION RATES (PRICES IN USD)
Thursday, May 13:
All delegates are encouraged to register for the meeting a • 8:45 – 9:30am: Drop-in networking in lounge
minimum of one week in advance of the start date to ensure • 2:45pm – 3:45pm: Round Table Discussions
that you receive your login details in time for the first day • 7:15pm – 8:00pm: Drop-in networking in lounge
of the meeting. It may take up to two business days to pro- Friday, May 14:
cess new registrations and provide login details after May • 7:15pm – 8:00pm: Drop-in networking in lounge
5, 2021.
CERTIFICATES OF ATTENDANCE
Regular “On-Site” Rate
Rate *Registration after May 5
All attendees will receive a certificate of attendance electron-
ISBER Member $370 $460 ically upon completing the post-conference delegate evalua-
tion. This will be distributed via email following the meeting.
Non-ISBER Member $460 $575
Technician/Student POSTER PRESENTATION INFORMATION:
$230 $230
Member
Posters are available in the “poster hall” throughout the
Registration for the annual meeting includes access to all live entirety of the meeting. Poster presenters will be available
and recorded content. Sessions recordings will continue to within their poster area for videoconferencing with dele-
be available for 60 days following the end of the meeting. gates during the two poster sessions:
Poster Session 1: Tuesday, May 11, 4:00pm – 5:00pm
Poster Session 2: Thursday, May 13, 4:00pm – 5:00pm
14PROGRAM
DESCRIPTION OF VIRTUAL SESSION TYPES
LIVE SESSIONS NETWORKING ACTIVITIES
The majority of sessions at the ISBER 2021 Annual Meeting The ISBER Annual Meeting will feature a networking lounge
will be live sessions. This means that you will attend them at that will be available throughout the entirety of the meeting
the time they are scheduled to take place in the program. for drop in networking. Specific networking sessions will
also take place in this lounge.
Within 24 hours of a live session, the recording of the ses-
sion will become available for on-demand viewing. The re- You are invited to hang out in the lounge during break times
cording will be available throughout the remainder of the to take advantage of this opportunity to connect with dele-
meeting and for 60 days following the event. gates from around the globe.
ON-DEMAND SESSIONS ROUND TABLE DISCUSSIONS
Some sessions at the ISBER 2021 Annual Meeting are pre-re- There are three round table discussion sessions scheduled
corded and available for viewing at your leisure. These ses- at the meeting. These are informal discussions with a facilita-
sions will become available for viewing at the start of the tor that allow delegates with similar interests to discuss hot
conference and will be available throughout the entirety of topics, challenges, and/or opportunities in biobanking.
the conference and for 60 days following the event. These are a great networking opportunity and all delegates
are encouraged to attend.
To access “on-demand” sessions, you will navigate to the
“on-demand” section in the virtual platform menu.
POSTER ABSTRACT PRESENTATIONS
WORKSHOPS The abstract posters will be available for viewing in the
“poster hall” throughout the entirety of the meeting. During
Educational workshops will be live, interactive sessions.
the specific poster presentation sessions in the program,
This means that you will attend them at the time they are
the poster presenters will be available within their poster
scheduled to take place in the program. Given the interac-
rooms for videoconferencing with delegates.
tive nature of workshops, only summary recordings will be
available for on-demand viewing following the session.
VISIT WITH EXHIBITORS
Workshops will take place via Zoom Meeting. If you are un-
able to install the Zoom application on your device you can Exhibit booths will be available throughout the entirety of
join using the web version of Zoom. the meeting in the “exhibit hall”. Exhibit staff will be avail-
The Biobanking 101 workshop recording is also available for able at their booths during the scheduled “visit with exhib-
purchase if you missed the session. Please visit www.isber. itors” sessions for videoconferencing with delegates. You
org to purchase this session. may also schedule meetings with exhibitor staff.
PLEASE JOIN US AT THE ISBER
ANNUAL GENERAL MEETING!
MAY 19, 2021 3:00 PM PDT / 6:00PM EDT / NEXT DAY 12:00AM CEST / NEXT DAY 6:00AM CST (CHINA) /
NEXT DAY 7:00AM JST (JAPAN) / NEXT DAY 8:00AM AEST (AUSTRALIA)
The Annual General Meeting of the International Society for Biological and Environmental Repositories will be held May
19, 2021. The meeting will be an electronic meeting. All members are invited to join the ISBER Annual General Meeting!
15
FOR MORE INFORMATION, VISIT: WWW.ISBER.ORG/PAGE/2021AGM OR EMAIL INFO@ISBER.ORGAll times listed in Americas Eastern Daylight Time PROGRAM
MEETING-AT-A-GLANCE
All times listed in Americas Eastern Daylight Time
WEDNESDAY, APRIL 28
2:30pm – 5:00pm BIOBANKING 101: PART 1 *Pre-registration is required
THURSDAY, APRIL 29
10:00am – 12:00pm BIOBANKING 101: PART 2 *Pre-registration is required
THURSDAY, MAY 6
All Day Virtual Platform Available for Browsing
11:00pm – 1:00am Technical Support Open
(next day)
FRIDAY, MAY 7
All Day Virtual Platform Available for Browsing
11:00am – 2:00pm Technical Support Open
MONDAY, MAY 10
8:30am – 5:00pm Technical Support Open
9:00am ALL ON-DEMAND SESSIONS BECOME AVAILABLE
9:00am – 5:00pm Exhibit Hall Open
9:30am – 10:45am WELCOME AND KEYNOTE
10:45am – 11:15am Visit with Exhibitors
11:15am – 1:45pm SYMPOSIUM 1A/1B
2:30pm – 5:00pm EDUCATIONAL WORKSHOPS 1/2/3
TUESDAY, MAY 11
8:30am – 5:00pm Technical Support Open
8:30am – 5:00pm Exhibit Hall Open
8:45am – 9:30am Coffee and Networking
9:30am – 9:45am TOP OF THE MORNING
10:00am – 12:45pm SYMPOSIUM 2A/2B
11:00am – 11:30am Visit with Exhibitors
1:30pm – 2:30pm CONTRIBUTED PAPER SESSIONS 1/2
16PROGRAM All times listed in Americas Eastern Daylight Time
TUESDAY, MAY 11
3:00pm – 4:00pm CORPORATE WORKSHOPS 1/2/3
4:00pm – 5:00pm POSTER PRESENTATIONS
7:15pm – 8:00pm Drop-in Networking
WEDNESDAY, MAY 12
8:30am – 5:00pm Technical Support Open
8:30am – 5:00pm Exhibit Hall Open
8:45am – 9:30am ROUND TABLE DISCUSSIONS
9:30am – 9:45am TOP OF THE MORNING
10:00am – 12:45pm SYMPOSIUM 3A/3B
11:00am – 11:30am Visit with Exhibitors
1:30pm – 4:00pm EDUCATIONAL WORKSHOPS 4/5/6
7:15pm – 8:00pm ROUND TABLE DISCUSSIONS
THURSDAY, MAY 13
8:30am – 5:00pm Technical Support Open
8:30am – 5:00pm Exhibit Hall Open
8:45am – 9:30am Coffee and Networking
9:30am – 9:45am TOP OF THE MORNING
10:00am – 12:30pm SYMPOSIUM 4A/4B
11:00am – 11:30am Visit with Exhibitors
1:15pm – 2:15pm CONTRIBUTED PAPER SESSIONS 3/4
2:45pm – 3:45pm ROUND TABLE DISCUSSIONS
4:00pm – 5:00pm POSTER PRESENTATIONS
5:00pm – 5:15pm CLOSING REMARKS
7:15pm – 8:00pm Drop-in Networking
FRIDAY, MAY 14
7:15pm – 8:00pm Drop-in Networking
17All times listed in Americas Eastern Daylight Time PROGRAM
MEETING PROGRAM
WEDNESDAY, APRIL 28
BIOBANKING 101: PART 1 *Pre-registration is required
Chair: Marianne Henderson
QUALIFICATION IN BIOREPOSITORY SCIENCE
2:30pm – 3:00pm
Brent Schacter, CancerCare Manitoba, Canada
2:30pm – 5:00pm
SUCCESS IS THE RESULT OF PREPARATION: EMERGENCY PLANNING FOR
3:00pm – 5:00pm BIOBANKING
Helen Morrin, University of Otago Christchurch, New Zealand, Rebecca Pugh, National Institute of
Standards and Technology, USA
THURSDAY, APRIL 29
BIOBANKING 101: PART 2 *Pre-registration is required
Chair: Debra Garcia
10:00am – 12:00pm BASIC BUSINESS PLANNING FOR BIOBANKING
Marianne Henderson, National Cancer Institute, USA, Daniel Simeon-Dubach, medservice, Switzerland, Kirstin Goldring,
AstraZeneca, UK
THURSDAY, MAY 6
All Day Virtual Platform Available for Browsing
11:00pm – 1:00am Technical Support Open
(next day)
FRIDAY, MAY 7
All Day Virtual Platform Available for Browsing
11:00am – 2:00pm Technical Support Open
MONDAY, MAY 10
8:30am – 5:00pm Technical Support Open
9:00am – 5:00pm Exhibit Hall Open
ON-DEMAND SESSIONS BECOME AVAILABLE:
RISING STARS: THE NEXT GENERATION OF BIOBANKERS
Chairs: Hanh Vu, Debra Garcia, Zisis Kozlakidis
This session aims to promote new stars in biobanking, including young biobanks, newbie biobankers, and
new achievements of biobanking. Show the world your first stone and your baby steps, let them know how
tough you are! This session creates a dancing zone for any early-stage aspects of biobanking. It is also a chance
to show your needs, and we are all together to help.
9:00am
OKADAI BIOBANK: BIOBANK-AS-A-SERVICE IN A UNIVERSITY HOSPITAL IN JAPAN
Mizuki Morita, Okayama University, Japan
THE CURRENT STATUS OF BIOBANKING IN VIETNAM
Tiến Anh Ngô, Vinmec Healthcare System, Vietnam
AN INDIAN EXPERIENCE WITH THE PROGRESS OF NATIONAL BIOBANK
18 Birendra Kumar Yadav, National Liver Disease Biobank, IndiaPROGRAM All times listed in Americas Eastern Daylight Time
MONDAY, MAY 10
EFFECT OF ASCORBIC ACID ON METABOLIC STATUS, LIPID PEROXIDATION, ANTIOXIDANT ACTIVITY
AND QUALITY OF FROZEN INDIAN RED JUNGLE FOWL (GALLUS GALLUS MURGHI) SEMEN
Bushra Allah Rakha, Pir Mehr Ali Shah Arid Agriculture University Rawalpindi, Pakistan
BIOBANK CANCER HOSPITAL: 14 YEARS IN TRANSLATION CANCER RESEARCH
Márcia Marques Silveira, Barretos Cancer Hospital, Brazil
WHAT YOU NEED TO KNOW TO COOPERATE WITH PHARMA AND THE DIAGNOSTICS INDUSTRY
Chairs: Pascal Puchois, Michael Roehrl
Since human biospecimens are a critical resource to translate research from bench to bedside, collaboration
between industry and biobanks is of paramount importance. This important collaboration is often sub-opti-
mal, as the parties each have their own unique priorities, requirements, and regulatory constraints. During
this session, we will explain the main drivers behind industry demand for biospecimens and the perspective
of academic biobanks, highlight some obstacles to collaboration, and explore potential solutions to optimize
co-operation.
This session has been organized by the ISBER Pharma Working Group.
WHAT ARE THE MAIN BIOSPECIMEN SOURCES USED BY PHARMA-IVD INDUSTRY?
Pascal Puchois, Trans-Hit Biomarkers, a Brooks Life Sciences Company, Canada
COLLABORATION BETWEEN ACADEMIC BIOBANKS AND BIOTECH INDUSTRY: PITFALLS AND
LESSONS LEARNED
Daniel Simeon-Dubach, medservice, Switzerland
MATERIAL TRANSFER AGREEMENTS: HOW TO ALIGN INDUSTRY’S AND ACADEMIA’S INTERESTS
Donna Wren, Faber Daeufer & Itrato P.C., USA
GETTING AN ASSAY TO MARKET: AN INTRODUCTION TO MEDICAL DEVICE REGISTRATION
Kerry Powers, Ventana, USA
9:00am THE SYNERGISTIC PARTNERSHIP BETWEEN PHARMA AND ACADEMIC PATHOLOGY FOR
COMPANION DIAGNOSTICS
Michael Roehrl, Memorial Sloan Kettering Cancer Center, USA
AN INCREASED NEED FOR BUILDING PROSPECTIVE FIT FOR PURPOSE BIOSPECIMEN COLLECTIONS:
IMPACT ON R&D PROGRAMS
Suresh Selvaraj, Genentech, USA
PRE-ANALYTIC VARIABLES IN A HIGH QUALITY BIOBANK WITH A FOCUS ON RECRUITING SUBJECTS
WHO ARE UNDER REPRESENTED IN BIOSPECIMEN COLLECTION
Chris Andry, Boston Medical Center, USA
LIQUID BIOPSY IN CANCER PATIENTS
Chair: Catherine Alix-Panabières
Biobanking, pre-analytical and analytical steps are important steps to detect circulating biomarkers in blood
samples from patients with a solid cancer. Liquid biopsy-based assays will be introduced in clinical routine in
the near future. However, we need to initiate more intervention clinical trials, combine different circulating
biomarkers depending on the cancer type, and define guidelines and SOP for their analyses.
INTRODUCTION
Catherine Alix-Panabières, University Medical Center Goettingen, Germany
BIOBANKING OF LIQUID BIOPSY IN LUNG CANCER: OPPORTUNITIES AND ISSUES
Paul Hofman, Université Côte d’Azur, France
EXTRACELLULAR VESIBLES: FROM CELL-CELL COMMUNICATION TO BIOMARKERS DISCOVERY
Bruno Costa -Silva, Champalimaud Foundation, Portugal
UTILITY OF CIRCULATING TUMOR DNA AS A RESPONSE AND FOLLOW-UP MARKER IN CANCER
THERAPY
Ellen Heitzer, Medical University of Graz, Austria
19All times listed in Americas Eastern Daylight Time PROGRAM
MONDAY, MAY 10
NON-CODING PATTERNS AND LIQUID BIOPSY
9:00am
George Calin, MD Anderson Cancer Center, USA
WELCOME AND KEYNOTE
Chairs: Amanda Moors, Benjamin Otto
Biobanking has evolved as a multidisciplinary field over the past two decades, and ISBER has been at the
forefront of all of the significant advances.
ISBER WELCOME AND OPENING REMARKS
9:30am – 9:40am
Daniel Catchpoole, ISBER President 2020-2021
9:30am – 10:45am ISBER 2021 ANNUAL MEETING BRIEF
9:40am – 9:50am
Amanda Moors, Benjamin Otto, ISBER 2021 Scientific Program Committee Co-Chairs
ISBER’S TWO DECADES OF CONNECTING AND COLLABORATING THROUGH
9:50am – 10:30am BIOBANKING
Jim Vaught, Biopreservation & Biobanking, USA
10:30am – 10:45am QUESTION AND ANSWER
10:45am – 11:15am Visit with Exhibitors
SYMPOSIUM 1A: LESSON TO BE LEARNED FROM THE COVID-19 PANDEMIC
Chairs: Amanda Moors, Benjamin Otto, Vanessa Tumilasci
Collaboration and sharing of expertise, of samples and of data across academia, industry and governmental
institutions is vital for medical research, for successful development of diagnostics tests and treatments, and
also for sustainability of research projects. The COVID-19 pandemic, in a microcosmic way, has made the value
of successful collaboration between medical centers, academia and the pharmaceutical and biotechnology
industries clearly visible. Never before have diagnostic tests and effective vaccines been developed in such a
short time. This success story, however, should not end with the recession of the COVID-19 pandemic – rather
it should be a rallying cry for more future collaboration. Within this session, we would like to reflect on the year
2020, on lessons learned, and obstacles and opportunities to foster closer co-operations across the aisle.
INTRODUCTION
11:15am – 11:25am
Benjamin Otto, Eppendorf, Germany
THE PATHWAY OF A SAMPLE FROM ACQUISITION TO VALUE CREATION
11:25am – 11:35am
Vanessa Tumilasci, Trans-Hit Biomarkers, a Brooks Life Sciences Company, Canada
LESSONS TO LEARN FROM THE CORONA PANDEMIC – INTENSE DATA- AND
SAMPLE TRANSFER AS KEY SUCCESS FACTOR FOR RAPID DEVELOPMENT OF
11:35am – 11:45am
DIAGNOSTIC TOOLS
11:15am – 1:45pm Andreas Pfützner, Pfützner Science & Health Institute, Germany
(Concurrent)
HUMAN ANTIBODIES FOR SARS-COV-2
11:45am – 11:55am
James Crowe, Vanderbilt University Medical Center, USA
SAMPLE REQUIREMENTS FOR THE DEVELOPMENT AND VALIDATION OF
NUCLEI ACID DETECTION AND SEROLOGICAL ASSAYS FOR EMERGING
11:55am – 12:05pm
PATHOGENS
Beatus Ofenloch-Haehnle, Roche Diagnostics, Germany, Chitra Manohar, Roche Diagnostics, USA
OBTAINING OPTIMAL HUMAN BIOLOGICAL SAMPLES TO SUPPORT CLINICAL
12:05pm – 12:15pm ASSAY DEVELOPMENT AND TESTING
Nikolaos Gaitatzis, Nexelis GSK, Germany
12:15pm – 12:35pm Networking Break with Exhibits
SPONSOR SHOWCASE: EXPAND THE FUTURE USE
OF BIOBANK SAMPLES USING NMR-BASED CLINICAL
12:35pm – 12:45pm
RESEARCH SOLUTIONS
Claire Cannet, Bruker BioSpin
12:45pm – 1:45pm PANEL DISCUSSION
20PROGRAM All times listed in Americas Eastern Daylight Time
MONDAY, MAY 10
SYMPOSIUM 1B: THE MICROBIOME - MAKING A MACRO-IMPACT
Chairs: Cari Lichtman, Helen Moore, Cathy Seiler
Publications for microbiome research have been increasing exponentially. Research shows microbiota impact
human, animal, plant, and environmental health significantly. By integrating sequencing and metabolomics,
researchers are looking for relationships between microbiomes, health, and disease. The aim of this session is
to showcase the possibilities and limitations associated with microbiome research.
INTRODUCTION
11:15am – 11:20am
Cari Lichtman, American Cancer Society, USA
ECOLOGICAL INTERPRETATION OF SKIN MICROBIOME
11:20am – 11:45am
Woo Jun Sul, Chung-Ang University, South Korea
MICROBIOMES FROM BIOREPOSITORIES
11:45am – 12:10pm
Stephen Greiman, Georgia Southern University, USA
11:15am – 1:45pm 12:10pm – 12:30pm Networking Break with Exhibits
(Concurrent)
SPONSOR SHOWCASE: EXPAND THE FUTURE USE
OF BIOBANK SAMPLES USING NMR-BASED CLINICAL
12:30pm – 12:40pm
RESEARCH SOLUTIONS
Claire Cannet, Bruker BioSpin
COLLECTING AND BANKING BIOSPECIMENS FOR MICROBIOME RESEARCH
12:40pm – 1:05pm IN LARGE COHORT STUDIES
Wei Zheng, Vanderbilt University Medical Center, USA
SARS-COV-2 DETECTION STATUS ASSOCIATES WITH BACTERIAL COMMUNITY
1:05pm – 1:30pm COMPOSITION IN PATIENTS AND THE HOSPITAL ENVIRONMENT
Lisa Marotz, University of California, San Diego, USA
1:30pm – 1:45pm QUESTION AND ANSWER
1:45pm – 2:30pm Networking Break with Exhibits
EDUCATIONAL WORKSHOP 1
ASSESSING AND ADDRESSING THE ETHICAL AND GOVERNANCE CHALLENGES OF NETWORKING
2:30pm – 5:00pm BIOREPOSITORIES
(Concurrent) Aaron Goldenberg, Case Western Reserve University, USA, Kyle Brothers, University of Louisville, USA, Jean Cadigan, University
of North Carolina, USA
EDUCATIONAL WORKSHOP 2
2:30pm – 5:00pm PRACTICAL APPLICATIONS OF DIGITAL PATHOLOGY AND ARTIFICIAL INTELLIGENCE IN BIOBANKING
(Concurrent) Anil Parwani, The Ohio State University, USA
EDUCATIONAL WORKSHOP 3
2:30pm – 5:00pm KEEPING BIOBANKING SIMPLE: IF KIDS GET IT, SO WILL YOU
Mandy Riffel, Children’s Mercy Hospital, USA, Daniel Catchpoole, The Children’s Hospital at Westmead, Australia, Suzanne
(Concurrent) Vercauteren, BC Children’s Hospital Biobank, Canada
21All times listed in Americas Eastern Daylight Time PROGRAM
TUESDAY, MAY 11
8:30am – 5:00pm Technical Support Open
8:30am – 5:00pm Exhibit Hall Open
8:45am – 9:30am Coffee and Networking
9:30am – 9:45am TOP OF THE MORNING AND AWARD PRESENTATION
Chairs: Debra Garcia, Amanda Moors, Benjamin Otto
SYMPOSIUM 2A: RESEARCH AND TREATMENT FOR ALL – CONNECTING RESEARCH AND
IMPLEMENTATION TO UNDERSERVED AND VULNERABLE COMMUNITIES
Chairs: Helen Morrin, Carol Weil
Biorepository specimens and data can only fulfill their potential to truly transform health and accelerate
scientific discovery if the outcomes are robust and meaningful for all. Biobanks need to be inclusive of all
populations, including the underserved and vulnerable communities to address the current lack of diversity
and genetic bias, in addition to reducing health disparities. The advent of precision medicine and increased
use of genomic tools (including WGS, WES, targeted gene panels, somatic sequencing in cancer, etc.) in
both clinical medicine and research has highlighted the urgency to acquire samples from diverse genetic
populations and ancestral communities to create meaningful results for all groups. Engagement with these
communities face additional challenges, requiring sensitive responses to building trust and partnerships, to
meet each community’s needs. This session will include a discussion of the stigma of COVID-19 positivity/
disease in these communities.
INTRODUCTION
10:00am – 10:10am Helen Morrin, University of Otago Christchurch, New Zealand, Carol Weil, National Institute of
Health, USA
10:00am – 12:45pm
(Concurrent) HOW TO FAIL AT CONNECTING WITH VULNERABLE AND UNDERSERVED
10:10am – 10:35am POPULATIONS TO IMPLEMENT TREATMENT AND RESEARCH
Paula Kim, TRAC-Translating Research Across Communities, USA
NEXUS BETWEEN SCIENCE AND SOCIETY: SOUTHERN AFRICAN EXPERIENCE
10:35am – 11:00am
Himladevi Soodyall, Academy of Science of South Africa (ASSAf), South Africa
11:00am – 11:30am Visit with Exhibitors
SPONSOR SHOWCASE: INNOVATIONS IN ULTRA-COLD
11:35am – 11:45am STORAGE AND COLD CHAIN TECHNOLOGY
Joe Laporte, PHC Corporation of North America, USA
RECRUITING BLACK AND BROWN WOMEN TO THE KOMEN TISSUE BANK: A
11:45am – 12:10pm MOTIVATIONAL ROADMAP
Kathi Ridley-Merriweather, Susan G. Komen Tissue Bank at the IU Simon Cancer Center, USA
12:10pm – 12:45pm PANEL DISCUSSION
SYMPOSIUM 2B: THE NURTURE OF NATURE: ENVIRONMENTAL BIOBANKING FOR A
CONNECTED WORLD
Chairs: Amanda Moors, Diane McGarvey, Piper Mullins
The vastly diverse environmental collections serve as an invaluable resource of knowledge--while this diver-
sity is necessary for the understanding of biodiversity, as well as other topics, it also introduces challenges to
maintaining a connectedness in a field that has historically been defined by what it is not (i.e., human). Since
plants, animals, archaea, and other environmental collections/samples do not possess a human voice, there
10:00am – 12:45pm is a risk that they will not be heard. Without the knowledge provided and preserved through environmental
(Concurrent) biobanking, though, there is an even greater risk to the prosperity of humanity. This symposium will provide
a platform for environmental biobanks to tell their stories about the diverse collections and the value they
provide for the biobanking community and beyond.
INTRODUCTION
10:00am – 10:05am Amanda Moors, National Institute of Standards and Technology, USA, Diane McGarvey, CHTN
Eastern Division, USA, Piper Mullins, Smithsonian Institution, USA
22PROGRAM All times listed in Americas Eastern Daylight Time
TUESDAY, MAY 11
INTEGRATING THE NORTH PACIFIC THROUGH TWO DECADES OF BANKING
10:05am – 10:30am SEABIRD EGGS
Stacy Schuur, National Institute of Standards and Technology, USA
THE NATURE OF NURTURERS AND NURTURERS IN NATURE; THE STORY OF
10:30am – 11:00am THE COLLABORATIVE BRISTOL BAY BELUGA PROJECT
Eric Gaglione, Georgia Aquarium, USA, Carrie Goertz, Alaska Sea Life Center, USA
11:00am – 11:30am Visit with Exhibitors
10:00am – 12:45pm SPONSOR SHOWCASE: INNOVATIONS IN ULTRA-COLD
(Concurrent) 11:30am – 11:40am STORAGE AND COLD CHAIN TECHNOLOGY
Joe Laporte, PHC Corporation of North America, USA
IMPLEMENTING A QUALITY MANAGEMENT SYSTEM IN CGIAR GENEBANKS:
IMPROVING THE ALIGNMENT OF PEOPLE, POLICY AND TECHNOLOGY IN
11:40am – 12:05pm
THE WORLD’S LARGEST AND MOST DIVERSE COLLECTIONS
Janny van Beem, Crop Trust, USA
BRAZILIAN GENETIC RESOURCES BIOBANKS NETWORK
12:05pm – 12:30pm
Samuel Paiva, Embrapa Genetic Resources and Biotechnology, Brazil
12:30pm – 12:45pm QUESTION AND ANSWER
12:45pm – 1:30pm Networking Break with Exhibits
CONTRIBUTED PAPER SESSION 1
Chair: Marianne Henderson, National Cancer Institute, USA
HLA TYPING FROM DRIED BLOOD SPOTS USING LIFECODES SSO TYPING KIT
Maemu Gededzha, University of the Witwatersrand Faculty of Health Sciences, South Africa
1:30pm – 2:30pm BIOBANKING IN THE ERA OF COVID-19: ETHICAL AND GOVERNANCE CHALLENGES
(Concurrent) Aaron Goldenberg, Case Western Reserve University, USA
COVID-19 BIOREPOSITORY – QATAR
Eleni Fthenou, Qatar Biobank for Medical Research, Qatar
CONTRIBUTED PAPER SESSION 2
Chair: Lotte Glück, Glück BioConsult, Switzerland
COORDINATING COVID-19 TISSUE PROCUREMENT FROM AUTOPSY: CHALLENGES AND LESSONS
LEARNED
Aubrey Schild, Duke University, USA
ESTABLISHMENT, IMPLEMENTATION AND UTILIZATION OF A HUMAN COVID-19 BIOSPECIMEN
BIOREPOSITORY AT UCLA
1:30pm – 2:30pm Clara Magyar, University of California Los Angeles David Geffen School of Medicine, USA
(Concurrent)
A PARADIGM SHIFT - RE-PURPOSING RESOURCES AND INFRASTRUCTURE DURING A PANDEMIC
TO ENSURE SUSTAINABILITY
Heidi Wagner, University Health Network, Canada
QCBIO-AF: QATAR CARDIOVASCULAR BIOREPOSITORY FOR FAMILIAL ATRIAL FIBRILLATION
Fatima Mohammed Qafoud, Qatar Foundation Research and Development, Qatar University, Qatar
2:30pm – 3:00pm Networking Break with Exhibits
23All times listed in Americas Eastern Daylight Time PROGRAM
TUESDAY, MAY 11
CORPORATE WORKSHOP 1: TRANSITIONING TO AN AUTOMATED BIOBANK:
ADVANTAGES, BEST PRACTICES AND CASE STUDY
Michelle Ng Almada, BiOS Product Manager, Hamilton Storage
3:00pm – 4:00pm CORPORATE WORKSHOP 2: BIOBANK SAMPLE QUALITY CONTROL WITH
(Concurrent) AUTOMATED ELECTROPHORESIS
Kyle Luttgeharm, Agilent Technologies, USA, Steffe Sandke, University Hospital Heildelberg, Germany
CORPORATE WORKSHOP 3: BREAKTHROUGH LABELING TECHNOLOGIES FOR
BIOBANKS AND HIGH-THROUGHPUT LABS
Domenic Di Paola, Senior Scientific Sales Manager, GA International, Canada
POSTER PRESENTATIONS
4:00pm – 5:00pm The poster presenters will be available to discuss their research with delegates via videoconferencing within
their poster area. This is an opportunity to ask questions of the presenters and network with fellow delegates.
DROP-IN NETWORKING
7:15pm – 8:00pm The evening networking activity is an opportunity to connect with delegates from the other side of the globe.
Delegates in the Indo-Pacific Rim and China will be just beginning their day.
WEDNESDAY, MAY 12
8:30am – 5:00pm Technical Support Open
8:30am – 5:00pm Exhibit Hall Open
ROUND TABLE DISCUSSIONS
Join us for informal discussions with your fellow delegates.
BIOBANKING IN LMICS IN THE POST COVID-19 ERA
Facilitator: Zisis Kozlakidis, International Agency for Research on Cancer, France
FEDERATED REPRESENTATION OF SPECIMENS COLLECTIONS IN CENTRAL REPOSITORY THROUGH
METADATA HARMONIZATION USING ESTABLISHED TERMINOLOGY STANDARDS
Facilitator: Michael Keller, Booz Allen Hamilton, USA
CHALLENGES AND TIPS FOR WRITING A PLAIN LANGUAGE CONSENT FORM
8:45am – 9:30am Facilitator: Helena Ellis, Biobanking Without Borders, LLC, USA
(Concurrent)
IMPACT OF NEW DIAGNOSTIC NMR-TOOLS ONBIOBANK SAMPLE QUALITY AND EFFICIENCY
Facilitator: Claire Cannet, Bruker BioSpin GmbH, Germany
THE FUTURE ROLE OF BIOBANKING IN THE COMING CELL AND GENE THERAPEUTICS REVOLUTION
Facilitator: Scott Masiella, Stirling Ultracold, USA
COMPLIANCE EXPERIENCE IN PHARMA USEFUL FOR ACADEMIC BIOBANKS?
Facilitator: Erik Steinfelder, Thermo Fisher Scientific, The Netherlands
9:30am – 9:45am TOP OF THE MORNING AND AWARD PRESENTATION
Chairs: Amanda Moors, Benjamin Otto, Debra Garcia
24PROGRAM All times listed in Americas Eastern Daylight Time
WEDNESDAY, MAY 12
SYMPOSIUM 3A: BIOBANKING IN THE FOOD INDUSTRY: WHERE STANDARDS ARE EASY TO
DIGEST!
Chairs: Daniel Catchpoole, Amanda Moors, Monique Albert
Many food industries have systematic stores of biological materials used in food production that have to be
maintained through to extremely high standards. Several international organizations or government agen-
cies currently cover biobanking for agriculture and food production. There are however gaps between gov-
ernments and commercial industry regarding the food production business sector and the role of biobank-
ing in these industries needs to be highlighted. This session will explore biobanks in the food industry and
their impacts of food standards and quality.
You are encouraged to bring the following items when attending this session: 1) a food package with a label
on it; 2) bottle of wine and a glass; 3) a jar of olives; 4) an egg; 5) oil; 6) mustard; 7) vinegar; 8) pepper; 9) a
small mixing bowl; 10) whisk or fork
INTRODUCTION
10:00am – 10:05am Daniel Catchpoole, Kids Research, The Children’s Hospital at Westmead, Australia
Amanda Moors, National Institute of Standards and Technology, USA
Monique Albert, Ontario Institute for Cancer Research, Canada
LESSONS LEARNED FROM THE NIST FOOD REFERENCE MATERIAL PROGRAM
10:00am – 12:45pm 10:05am – 10:35am
Melissa Meaney Phillips, National Institute of Standards and Technology, USA
(Concurrent)
OLIVE GENETIC RESOURCES CONSERVATION AND CATALOGUING IN THE
10:35am – 11:05am GERMPLASM BANK IOC NETWORK: GEN4OLIVE AND THOC PROJECTS
Concepcion Muñoz Díez, University of Cordoba, Spain
11:05am – 11:35am Visit with Exhibitors
SPONSOR SHOWCASE: THE HUNT STUDY
11:35am – 11:45am
Anne Jorunn Vikdal, HUNT biobank, Norway
FERMENTATION MICROBES-THE REAL WORKERS IN INNOVATIVE PRODUCTS
11:45am – 12:15pm FOR THE FUTURE
Simon Dillon, Australian Wine Research Institute, Australia
STANDARDS AND QUALITY IN YOUR KITCHEN
12:15pm – 12:25pm
Jeanette Simeon-Dubach, Directnetwork GmbH, Switzerland
12:25pm – 12:45pm QUESTION AND ANSWER
SYMPOSIUM 3B: BIOBANK SUSTAINABILITY IN LIGHT OF THE COVID-19 PANDEMIC
Chairs: Kirstin Goldring, Marianne Henderson, Daniel Simeon-Dubach
Sustainable behavior is a central focus for all research and clinical activities, including biobanking. The expe-
rience with the COVID-19 pandemic brought new challenges in all aspects of our lives, let alone our work.
It also has brought challenges as well as opportunities to sustained research biobanking and clinical care/
biobanking. This symposium will highlight biobanking from several perspectives, including biobanking to
serve the clinic and creation of the vaccines, as well as research biobanking. The speakers will share their
perspectives and lessons-learned from before, during and emerging from the pandemic, on the value and
10:00am – 12:45pm practicality of sustained biobanking. A panel discussion with audience participation will follow the talks.
(Concurrent)
INTRODUCTION
10:00am – 10:10am
Marianne Henderson, National Cancer Institute, USA
WHAT DID COVID TELL US ABOUT THE VALUE OF BIOBANKS?
10:10am – 10:30am
Phil Quinlan, University of Nottingham, UK
SUSTAINABLE COVID-19 SAMPLE COLLECTION IN CHALLENGING TIMES
10:30am – 10:50am
Amir Gander, University College London, UK
25You can also read
